Thrivent Financial for Lutherans’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Thrivent Financial for Lutherans’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-9,600	Closed	-$396K	–	1900
2015 Q2	$396K	Buy	9,600 +400	+4%	+$14.3K	﹤0.01%	1259
2015 Q1	$324K	Buy	9,200 +200	+2%	+$6.77K	﹤0.01%	1339
2014 Q4	$289K	Buy	9,000 +50	+0.6%	+$1.45K	﹤0.01%	1404
2014 Q3	$251K	Sell	8,950 -50	-0.6%	-$1.52K	﹤0.01%	1474
2014 Q2	$272K	Hold	9,000	–	–	﹤0.01%	1454
2014 Q1	$249K	Hold	9,000	–	–	﹤0.01%	1352
2013 Q4	$230K	Hold	9,000	–	–	﹤0.01%	1413
2013 Q3	$269K	Sell	9,000 -51,600	-85%	-$1.44M	﹤0.01%	1289
2013 Q2	$1.74K	Buy	+60,600	New	+$1.67M	0.01%	598

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Thrivent Financial for Lutherans's BRLI Position: Q3 2015 in Review

Thrivent Financial for Lutherans sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 9,600 shares — an estimated $396K sold.

Thrivent Financial for Lutherans first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $396K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Thrivent Financial for Lutherans reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Thrivent Financial for Lutherans sold 9,600 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $396K.
Thrivent Financial for Lutherans first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Thrivent Financial for Lutherans's BIO-REFERENCE LABS INC-NEW- position peaked at $396K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2015, filed 16 Nov 2015.